Tango Therapeutics, Inc. (TNGX) stock forecast and price target
Price $25.50 · data as of November 13, 2026
12-month price target
Average target$47.00
Upside / downside+84.3%
Analysts11
ConsensusStrong buy
Low $24.00Average $47.00High $68.00
Gold marker: average target · white marker: today’s price ($25.50)
Analyst ratings
Strong buy 1Buy 11Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.46 | −67.4% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.80 | −23.5% | $3M |
| Next quarter ends December 31, 2026 | $-0.35 | −21.0% | $0 |
| Quarter after ends December 31, 2026 | $-0.43 | −46.9% | $1M |
Consensus of the analysts covering Tango Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.
Frequently asked questions
What is the Tango Therapeutics stock price target?
The average 12-month target from 11 analysts is $47.00, 84.3% above the current price of $25.50 Targets range from $24.00 to $68.00.
Is Tango Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 11 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Tango Therapeutics expected to earn?
Analysts expect EPS of $-1.46 for the fiscal year ending December 31, 2026 and $-1.80 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.